- Home
- AVAV vs IMVT Comparison
AVAV vs IMVT Comparison
Compare AVAV & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAV
- IMVT
- Stock Information
- Founded
- AVAV 1971
- IMVT N/A
- Country
- AVAV United States
- IMVT United States
- Employees
- AVAV N/A
- IMVT N/A
- Industry
- AVAV Aerospace
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVAV Industrials
- IMVT Health Care
- Exchange
- AVAV Nasdaq
- IMVT Nasdaq
- Market Cap
- AVAV 4.4B
- IMVT 3.6B
- IPO Year
- AVAV 2007
- IMVT N/A
- Fundamental
- Price
- AVAV $154.79
- IMVT $21.27
- Analyst Decision
- AVAV Buy
- IMVT Strong Buy
- Analyst Count
- AVAV 6
- IMVT 12
- Target Price
- AVAV $225.20
- IMVT $45.90
- AVG Volume (30 Days)
- AVAV 388.1K
- IMVT 1.5M
- Earning Date
- AVAV 03-04-2025
- IMVT 02-06-2025
- Dividend Yield
- AVAV N/A
- IMVT N/A
- EPS Growth
- AVAV N/A
- IMVT N/A
- EPS
- AVAV 1.72
- IMVT N/A
- Revenue
- AVAV $761,498,000.00
- IMVT N/A
- Revenue This Year
- AVAV $16.93
- IMVT N/A
- Revenue Next Year
- AVAV $22.42
- IMVT N/A
- P/E Ratio
- AVAV $89.87
- IMVT N/A
- Revenue Growth
- AVAV 16.51
- IMVT N/A
- 52 Week Low
- AVAV $121.63
- IMVT $19.07
- 52 Week High
- AVAV $236.60
- IMVT $39.55
- Technical
- Relative Strength Index (RSI)
- AVAV 37.17
- IMVT 47.11
- Support Level
- AVAV $153.97
- IMVT $20.41
- Resistance Level
- AVAV $161.61
- IMVT $21.43
- Average True Range (ATR)
- AVAV 7.75
- IMVT 1.13
- MACD
- AVAV -2.65
- IMVT 0.23
- Stochastic Oscillator
- AVAV 4.55
- IMVT 54.52
About AVAV AeroVironment Inc.
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).